Status:
UNKNOWN
Evaluation of pentraxin3 as a Marker for Ventilator Associated Pneumonia
Lead Sponsor:
Assiut University
Conditions:
Ventilator Associated Pneumonia
Eligibility:
All Genders
18+ years
Brief Summary
This study will assess the role of pentraxin3 (PTX3) in the early diagnosis of ventilator-associated pneumonia (VAP) and the detection of antibiotic sensitivity for different organisms isolated from t...
Detailed Description
Ventilator associated pneumonia (VAP) is a type of hospital-acquired pneumonia that occurs more than 48h after endotracheal intubation. This can be further classified into early onset (within the firs...
Eligibility Criteria
Inclusion
- study will be conducted on adult patients \>18 years who will have VAP in intensive care unit (ICU) of chest department of Assiut university hospital.
Exclusion
- Patients with age \<18 years .
- Patients with any hospital acquired infections other than VAP.
Key Trial Info
Start Date :
February 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2021
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04111224
Start Date
February 1 2020
End Date
February 1 2021
Last Update
January 14 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.